Recon: GSK to buy Affinivax for up to $3.3B; FDA approves Roche’s SMA drug Evrysdi for infants under 2 months old
ReconMichael Mezher
Biologics/ biosimilars/ vaccinesBiotechnologyDiagnostics/IVDsEuropeGlobalMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/Policy